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A B S T R A C T
Background
Urinary incontinence can affect 40-60% of people admitted to hospital after a stroke, with 25% still having problems on hospital
discharge and 15% remaining incontinent at one year.
Objectives
To determine the optimal methods for treatment of urinary incontinence after stroke in adults.
Search methods
We searched the Cochrane Incontinence and Stroke Groups specialised registers (searched 15 March 2007 and 5 March 2007 respec-
tively), CINAHL (January 1982 to January 2007), national and international trial databases for unpublished data, and the reference
lists of relevant articles.
Selection criteria
Randomised or quasi-randomised controlled trials evaluating the effects of interventions designed to promote continence in people
after stroke.
Data collection and analysis
Data extraction and quality assessment were undertaken by two reviewers working independently. Disagreements were resolved by a
third reviewer.
Main results
Twelve trials with a total of 724 participants were included in the review. Participants were from a mixture of settings, age groups and
phases of stroke recovery.
Behavioural interventions
Three trials assessed behavioural interventions, such as timed voiding and pelvic floor muscle training. All had small sample sizes and
confidence intervals were wide.
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Specialised professional input interventions
Two trials assessed variants of professional input interventions. Results tended to favour the intervention groups: in a small trial in early
rehabilitation, fewer people had incontinence at discharge from hospital after structured assessment and management than in a control
group (1/21 vs. 10/13; RR 0.06, 95% CI 0.01 to 0.43); in the second trial, assessment and management by Continence Nurse Advisors
was associated with fewer participants having urinary symptoms (48/89 vs. 38/54; RR 0.77, 95% CI 0.59 to 0.99) and statistically
significantly more being satisfied with care.
Complementary therapy interventions
Three small trials all reported fewer participants with incontinence after acupuncture therapy (overall RR 0.44; 95% 0.23 to 0.86), but
there were particular concerns about study quality.
Pharmacotherapy and hormonal interventions
There were three small trials that included groups allocated meclofenoxate, oxybutinin or oestrogen. There were no apparent differences
other than in the trial of meclofenoxate where fewer participants had urinary symptoms in the active group than in the control group
(9/40 vs. 27/40; RR 0.33, 95% CI 0.18 to 0.62).
Authors’ conclusions
Data from the available trials are insufficient to guide continence care of adults after stroke. However, there was suggestive evidence
that professional input through structured assessment and management of care and specialist continence nursing may reduce urinary
incontinence and related symptoms after stroke. Better quality evidence is required of the range of interventions that have been suggested
for continence care after stroke.
P L A I N L A N G U A G E S U M M A R Y
Treatment of urinary incontinence after stroke in adults
Urinary incontinence is a common consequence of stroke and has many causes. In early stroke rehabilitation, structured assessment
and management of care shows promise in reducing the number of people with urinary incontinence. In the later phases of stroke
recovery the use of specialist advisors may be helpful in reducing symptoms associated with urinary incontinence. Even late after stroke,
interventions targeted at specific causes of incontinence may be helpful. Unfortunately, all the conclusions were limited by a lack of
robust information.
B A C K G R O U N D
Urinary incontinence is defined as the complaint of any invol-
untary leakage of urine (Abrams 2002). 40-60% of people ad-
mitted to hospital after a stroke can have problems with urinary
incontinence, with 25% of stroke survivors still having problems
on hospital discharge, and 15% remaining incontinent after one
year (Barrett 2001). Not all the studies reviewed by Barrett 2001
excluded people with pre-morbid incontinence, however, so fig-
ures presented may include old as well as new cases. Addressing
problems with continence whilst the person is still in hospital may
prevent long-term problems for the patient and family.
The more severe the stroke, the greater is the likelihood of urinary
incontinence (Burney 1996a). Other risk factors for urinary in-
continence include older age, female sex, speech difficulties, mo-
tor weakness, visual field defects or cognitive impairment (Barrett
2001). Problems experiencedmay range from urinary retention to
complete incontinence. The most likely pattern of incontinence
is urinary frequency, urgency (a sudden compelling desire to pass
urine which is difficult to defer) and urge incontinence (involun-
tary leakage) (Marinkovic 2001). This is generally the result of
detrusor overactivity (Arunabh 1993), although this may depend
on the site of the stroke lesion (Burney 1996b).
Damage to the frontal lobe, the area believed to be responsible for
control of micturition, has been identified in several studies as as-
sociated with urinary dysfunction after stroke. However, evidence
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suggests that the size of the lesion, rather than its location, is more
likely to predict urinary incontinence (Brittain 1999). It is unclear
whether incontinence is a direct (i.e. site of brain lesion) or indi-
rect (e.g. functional impairment preventing access) consequence
of stroke. Other non-neurological factors contributing to urinary
incontinence, including pre-morbid continence state, sphincter
incompetence and polyuria (Barrett 2001), are regarded as preva-
lent in the population of patients with stroke (Brittain 1998b).
Because of their severity, the symptoms of urinary incontinence are
reported to have more of an effect on the lives of stroke survivors,
when compared with other groups of people with incontinence
(Brittain 2000b). Urinary symptoms had more impact on sleep,
daily activities, quality of life, physical discomfort, social life and
relationships. Incontinence is not just a physical problem, but
impacts on what people can do and how they feel. Depression is
twice as common in stroke survivors who are incontinent (Brittain
1998a). Urinary incontinence is distressing for both those affected
and their carers (Williams 1993).
Continuing incontinence is associated with poor outcome in both
stroke survivor and carer (Nakayama 1997). Conversely, stroke
outcome is better in those stroke survivors who remain continent
or regain continence (Barer 1989). Improvement is common over
time (Marinkovic 2001), which suggests that problems with conti-
nence may be transient in some stroke survivors, and/or amenable
to intervention. Factors predicting early improvements in conti-
nence status are less impairment on admission, and the site of the
stroke lesion (Ween 1996). Factors associated with poor recovery
of continence include stroke type and being aged 75 or over (Patel
2001).
Incontinence is a strong predictor of stroke functional outcome
(Meijer 2003). While there are problems with attributing better
stroke outcome to improvements in continence, it is possible that
recovery from incontinence may improve morale and self esteem
and therefore speed overall stroke recovery (Barer 1989; Patel
2001).While differences in incontinence rates between centreswill
reflect difference in the case mix of individuals and the methods
of reporting (Barrett 2001), they might also indicate variations in
the processes of continence assessment and management.
It is known that early rehabilitation intervention in stroke results
in better outcome overall (Cifu 1999). Some of the studies on
which this conclusion is based have included incontinence as a
measure of functional outcome. For example, a trial of a multidis-
ciplinary rehabilitation intervention aiming to improve functional
independence after stroke showed a positive impact on inconti-
nence rates (Wikander 1998a). Othermanagement techniques in-
clude biofeedback, pelvic floor muscle training, electrical stimula-
tion, drug treatments, surgical interventions and mechanical de-
vices.
Current guidelines for the management of urinary incontinence
recommend an assessment to guide management (Thuroff 1999).
This begins with physical assessment and history-taking includ-
ing identification of urological problems before the stroke oc-
curred, such as bladder outlet obstruction in men or stress incon-
tinence in women. The choice of method to promote continence
will then depend on the individual’s history and type of inconti-
nence. Bladder training and/or anticholinergic drugs may be ap-
propriate for urge incontinence, while problems with retention
may require intermittent catheterisation. Alternatively, problems
with memory loss or restriction of movement may benefit more
from toileting assistance programmes such as prompted or timed
voiding or habit retraining (Eustice 2000; Ostaszkiewicz 2004a;
Ostaszkiewicz 2004b; Roe 2007 ).
A systematic review of methodologically robust studies - ran-
domised controlled trials - is needed to identify interventions to
promote continence that are effective in the stroke population. Tri-
als that have evaluated different management strategies also need
to be reviewed in relation to subgroups of stroke patients with
specific patterns of incontinence, because the effects of manage-
ment are likely to depend on the type of stroke that the person has
suffered and the urinary problems they experienced.
O B J E C T I V E S
The objective of this review was to determine the optimal methods
for the treatment of urinary continence after stroke in adults.
The following hypotheses were addressed:
1. intervention is more effective than no intervention;
2. intervention is more effective than placebo;
3. a specific intervention is more effective in comparison with
another intervention;
4. combined interventions are more effective than single interven-
tions.
Within each hypothesis, interventionswere consideredwithin four
categories:
1. behavioural interventions
2. specialised professional input interventions
3. complementary therapy interventions
4. pharmacotherapy interventions.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
All randomised and quasi-randomised trials evaluating the effects
of interventions designed to promote continence in people who
have had a stroke. Quasi-random methods include: allocation by
the person’s date of birth, by the day of the week or month of the
year, by a person’s medical record number, or just allocating every
alternate person.
Types of participants
Adults (i.e. 18 years of age and over) with a diagnosis of stroke,
including people with incontinence who have had a stroke iden-
tified as a subgroup within a larger group for whom relevant data
are reported.
Types of interventions
One arm of the study must include an intervention designed to
promote urinary continence. Trials evaluating any of the following
were included in the review:
• pharmacotherapy e.g. anticholinergics, adrenergics,
hormonal treatment;
• physical therapy e.g. electrical stimulation, biofeedback;
• physical aids e.g. catheters, pads, pessaries, other appliances;
• behavioural interventions e.g. prompted or scheduled
voiding, bladder training, habit retraining (i.e. identification of
voiding pattern and development of an individualised toileting
schedule), pelvic floor muscle training or other behavioural
management programmes;
• environmental or lifestyle interventions e.g. voiding
position, diet and fluid management, alternative communication
devices;
• specialised professional input interventions e.g. provision of
information or education, assessment schedules, generic
multidisciplinary rehabilitation programmes, Continence
Advisors, home-support programmes, nurse practitioners;
• complementary interventions e.g. homeopathy,
acupuncture.
Trials relating solely to surgical or physical interventions for pre-
existing continence problems that are not associated with stroke
(e.g. transurethral resectionof the prostate)were excluded, unless it
was a co-intervention in awider trial testing an includedmethod of
continence promotion. Trials relating to urological diagnosis, or to
themanagement of incontinence or retention of urine in the acute
phase of stroke were also excluded. The acute phase was defined
as up to one month post stroke. Studies were excluded if solely in
the acute phase because the aim of intervention is commonly to
contain incontinence, monitor urine output and prevent adverse
events, rather than promote continence.
Types of outcome measures
The primary outcome of interest was in/continence, measured by:
1. Participant symptoms
• Number of participants regaining continence
• Number of incontinent episodes over 24 hours (indicated
by bladder charts, total and mean number of episodes)
• Severity of incontinence e.g. index score
• Perception of improvement or cure in continence (as
reported by participant or caregiver)
2. Physical measures
• Pad tests of quantified leakage
• Volume of urine loss
• Total and mean number of pads used
3. Secondary outcomes
a) Symptom scores or participant /carer report of other urinary
symptoms including frequency, urgency, dysuria, polyuria, noc-
turia, discomfort, pain
b) Physical measures e.g. post-void retention of urine, time to
voiding onset, void volume, urodynamic measures
c) Health status or measures of psychological health
Impact of incontinence e.g. Incontinence Impact Questionnaire
(IIQ), Short Form 36 Health Survey Questionnaire (SF36), func-
tional ability, knowledge, satisfaction, quality of life
d) Economic outcomes
Impact of continence promotion interventions on cost or service
use
e) Other outcomes
Any other outcomes subsequently deemed appropriate to the re-
view.
Search methods for identification of studies
The review used the search strategies developed for both the
Cochrane Incontinence Group and the Cochrane Stroke Group.
Relevant trials were initially identified from the Groups’ spe-
cialised registers of controlled trials described under the groups’
details in The Cochrane Library (For more details please see the
‘Specialized Register’ section
of the Incontinence Group’s module in The Cochrane Library) (
For details of the Stroke Group’s Specialised Register please
see the ’Specialized Register’ section of their module). The dates
of the most recent searches of the registers for this review update
were conducted on 15March 2007 (Stroke Register) and 5March
2007 (Incontinence Register).
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To search the Stroke Group register the following search terms
were used: “incontinence (urine/faecal) or (nursing and bladder
care) or urinary retention or urinary tract infection”.
The terms used to search the Incontinence Group trials register
are given below:
(({Topic.urine.incon.Stroke.} OR
{TOPIC.URINE.INCON.UNKNOWN.STROKE.}
OR {TOPIC.URINE.INCON.NEUROGENIC.} (in keywords
field))
OR
({stroke\*} OR {cerebrovascular\*} (in title1 field))
OR
({TOPIC.URINE.NEUROGENIC.} OR
{TOPIC.URINE.NEUROGENIC.stroke.} (in keywords field)))
AND
({DESIGN.CCT*} OR {DESIGN.RCT*} (in keywords field))
(All searches were in Reference Manager 9.5 N, ISI ResearchSoft).
The following extra specific searches were performed for this re-
view. For more details, including the search terms used please see
Appendix 1.
We did not impose any language or other restrictions on any of
these searches.
Electronic searches
Due to the comprehensive nature of the searches already performed
by the Cochrane Stroke Group, no additional searches were per-
formed other than on CINAHL, combining stroke terms with
terms for urinary incontinence without a research methods fil-
ter. The search was combined with the CINAHL search from the
Cochrane Stroke Group. This was done because of the potentially
poor indexing of nursing research. The CINAHL search covered
the years January 1982 to January 2007 (on Dialog Datastar).
More details, including search terms are given in Appendix 1.
Recent unpublished trial data were also searched for on national
and international databases i.e. NHS National Research Register,
NHSResearch Findings Register, USCommunity of ScienceNIH
Grants, MetaRegister of Controlled Clinical Trials and CRISP, by
adapting terms drawn from the existing search strategies of the
Incontinence and Stroke Review Groups.
Searching other resources
The reference lists of all relevant reviews and trial reports were
searched to identify further relevant studies. Major investigators
were contacted to ask for any other possible relevant trials, pub-
lished or unpublished. In addition, contact was made with the
authors of other relevant Cochrane reviews to ascertain whether
defined subgroups of stroke survivors were identified in trials test-
ing methods of promoting continence in a general population.
The reviewwas publicised on the followingwebsites: JoannaBriggs
Institute, Royal College of Nursing Research Society, Royal Col-
lege of Nursing Continence Interest Group, Association of Con-
tinence Advisors, Sigma Theta Tau.
Data collection and analysis
Trials were considered for inclusion independently by two review-
ers (LT, BF). Studies were excluded from the review if they were
not randomised or quasi-randomised, or if on more detailed ex-
amination, they did not meet the review inclusion criteria. These
studies are listed in the ’Characteristics of Excluded Studies Table’.
Data extraction forms, based on the protocol, were piloted and
checked for the coding of intervention, outcome and quality as-
sessment. Data extraction and review of the methodological qual-
ity of the eligible studies was independently conducted by two
reviewers for each study (SC, BF, ML, LT) using the quality as-
sessment tool described by the Cochrane Incontinence Review
Group. Extracted data and quality assessment were cross checked
and any disagreements discussed and if necessary resolved by a
third reviewer (LT).
Attempts were made to obtain missing data, as well as data col-
lected but not reported, by contacting trialists.
Outcomes are reported as unfavourable events. Planned subgroup
analyses for the effect of urological diagnosis (i.e. detrusor over-
activity versus other) and time from stroke onset (1 to 6 months,
greater than 7months) were not possible as the data were not avail-
able in the original studies. Included trial data were processed as
described in the Cochrane Authors’ Handbook (Deeks 2006), and
analysed using the statistical analysis package RevMan Analyses.
Effect estimates for continuous outcomes were summarised using
weighted mean difference (WMD) and dichotomous outcomes
were summarised using relative risk (RR). Where deemed appro-
priate, effects were summarised across studies using fixed or ran-
dom effects meta-analysis techniques appropriate to the form of
the data. Random effects meta-analysis (DerSimonian and Laird
method) was used if the studies showed heterogeneity (defined
by the studies’ effects having an I-squared statistic of greater than
50%), otherwise a fixed effect analysis (Mantel-Haenszel for di-
chotomous and inverse variance for continuous data) was used.
For continuous outcome data, if change from baseline data were
available, these were used; otherwise the raw outcome data were
used.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
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Included/excluded studies
The search identified 1234 papers and 126 studies were retrieved.
The search initially identified ten potential trials evaluating the
effectiveness of methods to promote continence in adults after
stroke (Brittain 2000a; Chu 1997; Cook 1998; Gelber 1997a;
Gelber 1997b; Gross 1990; Judge 1969; Lewis 1990; Tekeoglu
1998; Wikander 1998b).
One trial was published in Chinese, one in Korean, and the rest
in English. Information from the Chinese trial was translated and
extracted by nursing lecturers from the Shanghai Military Medi-
cal University. On further examination, three trials (Cook 1998;
Gross 1990; Tekeoglu 1998) were excluded for reasons listed in
the ’Characteristics of Excluded Studies Table’.
The review update identified a further five studies (Liu 2006;
Tibaek 2005; Zhang 2002; Zhou 1999; Zhu 2003). With the ex-
ception of Tibaek 2005, all were published in Chinese and were
translated by a native speaking Chinese nursing student undertak-
ing postgraduate study in England.
Twelve trials were therefore included in the review update: seven
were full reports (Brittain 2000a; Chu 1997; Judge 1969; Liu
2006; Tibaek 2005; Wikander 1998b; Zhu 2003), although one
Chinese trial (Chu 1997) was only briefly described in a one page
report; the remaining five trials were reported only in conference
abstracts (Gelber 1997a; Gelber 1997b; Lewis 1990; Zhang 2002;
Zhou 1999). Two of the trials (Gelber 1997a; Gelber 1997b) were
in parts of the same report.
Description of interventions
The trials tested the following interventions:
Behavioural interventions
• timed voiding versus void on request (Gelber 1997a);
• oxybutynin versus timed voiding (Gelber 1997b);
• pelvic floor muscle training versus usual care (Tibaek 2005);
• sensory-motor biofeedback device (Uristop) combined with
timed voiding against timed voiding alone (Lewis 1990).
Specialised professional input interventions:
• care from a Continence Nurse Advisor (CNP) versus usual
care provided by the general practitioner (GP) (Brittain 2000a);
• a special intervention programme based on assessment
using the Functional Independence Measure (FIM) versus usual
rehabilitation care (Wikander 1998b).
Complementary therapy interventions:
• scalp acupuncture versus no scalp acupuncture (Chu 1997);
• eye and scalp acupuncture versus no acupuncture (Zhou
1999);
• acupuncture versus usual care (Zhang 2002);
• ginger-salt-partitioned moxibustion (involving filling the
navel with salt, adding a piece of ginger and a taper and setting
the taper alight) plus routine acupuncture versus routine
acupuncture (Liu 2006).
Pharmacotherapy interventions:
• oestrogen versus placebo (Judge 1969);
• meclofenoxate (designed to improve glucose utilisation of
brain cells) plus salvia miltirrhiza versus salvia miltirrhiza (Zhu
2003);
• oxybutynin versus timed voiding (Gelber 1997b);
Physical therapy interventions:
• sensory-motor biofeedback device (Uristop) combined with
timed voiding against timed voiding alone (Lewis 1990).
Intervention versus no intervention / usual care
Nine trials tested an intervention versus no intervention or usual
care (Brittain 2000a; Chu 1997; Gelber 1997a; Liu 2006; Tibaek
2005; Wikander 1998b; Zhang 2002; Zhou 1999; Zhu 2003).
Behavioural interventions
One trial (Gelber 1997a) tested a behavioural intervention com-
prising timed voiding versus void on request for participants with
normal urodynamic studies. Normal urodynamic studies was not
defined and no further details are given of the intervention. One
trial (Tibaek 2005) tested an intensive pelvic floor muscle training
programme, comprising individual and group exercises and feed-
back to participants, compared against normal rehabilitation with
no specific treatment of urinary incontinence.
Specialised professional input interventions
Two trials (Brittain 2000a; Wikander 1998b) tested specialised
professional input interventions. Brittain 2000a compared care
given by a Continence Nurse Advisor against usual care provided
by a general practitioner and existing specialised services for the
management of continence. Wikander 1998b compared the im-
pact of a special intervention programme based on assessment us-
ing the Functional Independence Measure against usual rehabili-
tation care based on the Bobath method.
Complementary therapy interventions
Four trials tested complementary interventions. Chu 1997 tested
scalp acupuncture plus usual care, compared against usual care
with no scalp acupuncture; Zhang 2002 tested acupuncture
against general treatment and Zhou 1999 tested eye and electrifer-
ous scalp acupuncture plusmedication therapy against medication
therapy only. Liu 2006 tested ginger-salt-partitioned moxibustion
plus routine acupuncture against routine acupuncture.
Pharmacotherapy interventions
One trial (Zhu 2003) tested meclofenoxate plus salvia miltirrhiza
against salvia miltirrhiza alone.
Intervention versus placebo
One cross-over trial (Judge 1969) tested a pharmacotherapy inter-
vention (oestrogen) against placebo.
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Specific intervention versus another intervention
One trial (Gelber 1997b) tested a specific intervention against
another intervention, comparing the anticholinergic oxybutynin
against timed voiding in participants with bladder hyperreflexia.
Combined intervention versus single intervention
One trial (Lewis 1990) tested a combined intervention against a
single intervention. The study tested a sensory-motor biofeedback
device combined with timed voiding, against timed voiding alone.
Participants
A total of 724 participants were enrolled in the trials. The numbers
in individual trials ranged from 13 to 242. Two trials (Judge
1969; Tibaek 2005) enrolled only female participants. Three trials
(Gelber 1997a;Gelber1997b; Lewis 1990) gave nodetails of age or
gender. The remaining trials (Brittain 2000a;Chu1997; Liu 2006;
Wikander 1998b; Zhang 2002; Zhou 1999; Zhu 2003) ranged
from 40% to 61% males. The mean age of the study participants
overall cannot be reported, but the highest mean age (82) was in
the trial by Judge (Judge 1969), with the widest age range of 40-
96 in the Brittain trial (Brittain 2000a).
Diagnosis
Three trials (Liu 2006; Tibaek 2005; Wikander 1998b) only in-
cluded participants who were continent prior to the stroke. Nine
trials (Brittain 2000a; Chu 1997; Gelber 1997a; Gelber 1997b;
Judge 1969; Lewis 1990; Zhang 2002; Zhou 1999; Zhu 2003) did
not specify whether urinary incontinence was subsequent to the
occurrence of stroke, although Lewis 1990 described participants
as having “post-stroke urinary urge incontinence”.
Diagnostic criteria for incontinence were given in only two trials
(Brittain 2000a; Tibaek 2005). Four trials specified a urological di-
agnosis, given as normal urodynamic studies (Gelber 1997a), blad-
der hyperreflexia (Gelber 1997b), urge incontinence (Lewis 1990)
and urge, stress andmixed stress/urge incontinence (Tibaek 2005).
Judge 1969 reported data for two groups of participants defined
as mildly or severely incontinent. Liu 2006 reported data for three
groups of participants, classified according to the Barthel conti-
nence item: completely incontinent, partially incontinent and in-
dependent. Chu 1997 included participants who had “urinary fre-
quency or urinary incontinence” but did not define urinary fre-
quency further. Two trials (Brittain 2000a; Wikander 1998b) did
not include a urological diagnosis for participants, or group them
by type of incontinence.
The trial by Tibaek 2005 stated that participants must be diag-
nosed according to the World Health Organisation definition of
ischaemic stroke verified by CT scan. Three trials (Gelber 1997a;
Gelber 1997b; Wikander 1998b) reported that strokes were uni-
lateral, and one trial (Chu 1997) reported the stroke type as multi-
focal infarction. Liu 2006 and Zhou 1999 included participants
with cerebral infarction andhaemorrhage. Two trials (Zhang 2002;
Zhu 2003) included only participants with infarction, and the site
of infarction is specified for all participants in the trial by Zhang
2002. Judge 1969 included participants with cerebrovascular ac-
cident or “multiple little strokes”. Brittain 2000a included partic-
ipants who self-reported that they had had a stroke, subarachnoid
haemorrhage or transient ischaemic attack on a screening ques-
tionnaire. One trial (Wikander 1998b) included side of stroke le-
sion in baseline comparison between groups.
It was not possible in all but one of the trials (Tibaek 2005) to
determine whether only participants with a first stroke were in-
cluded. Participants in two trials (Wikander 1998b; Zhu 2003)
were in the acute phase of stroke (i.e. 0 to 1 month) on enrolment
to the study, but in one study (Wikander 1998b) the study period
extended into early rehabilitation, i.e. up to three months. Par-
ticipants in the trial by Liu 2006 were 70.74 ± 35.26 days post-
stroke, while Zhou 1999 presented findings for participants who
were less than or more than three months post-stroke. Participants
in three trials (Brittain 2000a; Judge 1969; Tibaek 2005) were also
less likely to be in the early rehabilitation phase, as they were either
occupying long-stay geriatric hospital beds or living at home. It is
difficult to identify the phase of stroke recovery for participants in
the other trials (Chu 1997; Gelber 1997a; Gelber 1997b; Lewis
1990; Zhang 2002).
Five trials (Brittain 2000a; Judge 1969; Liu 2006; Tibaek 2005;
Zhu 2003) reported exclusion criteria. The remaining seven trials
did not detail inclusion or exclusion criteria (Chu 1997; Gelber
1997a; Gelber 1997b; Lewis 1990;Wikander 1998b; Zhou 1999;
Zhang 2002). Three trials (Liu 2006; Tibaek 2005; Wikander
1998b) reported detailed baseline comparisons.
Setting
Care was provided in a hospital setting in five of the trials: on
a rehabilitation ward in a Department of Geriatrics in Sweden (
Wikander 1998b); in two long stay geriatric wards in two hospitals
in Scotland (Judge 1969) and in hospitals in China (Liu 2006;
Zhu 2003) and Denmark (Tibaek 2005) (although participants
were outpatients at the time of this study). Brittain 2000a included
participants living in the community in England, excluding those
living in residential care. The six remaining trials do not specify
the setting of care (Chu 1997; Gelber 1997a; Gelber 1997b; Lewis
1990; Zhang 2002; Zhou 1999).
Description of outcomes
Outcomes addressed by the trials were diverse. Six trials expressed
the primary outcome as the number of people with urinary in-
continence (Brittain 2000a; Chu 1997; Lewis 1990; Wikander
1998b; Zhang 2002; Zhou 1999), with six trials reporting num-
ber of incontinent episodes (Gelber 1997a; Gelber 1997b; Judge
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1969; Lewis 1990; Liu 2006; Tibaek 2005). One trial (Brittain
2000a) also reported ameasure of the severity of incontinence. The
trials also measured primary outcomes at different time points.
In terms of secondary outcomes, four trials measured urinary
symptoms (Brittain 2000a; Liu 2006; Tibaek 2005; Zhu 2003).
One trial (Tibaek 2005) included a physical measure of inconti-
nence in the form of pad tests of quantified leakage. Four trials
measured functional and psychological outcomes (Brittain 2000a;
Tibaek 2005; Wikander 1998b; Zhu 2003). One trial included
an economic measure (Wikander 1998b).
All outcomes reported in the original trials are included in the
review, except global functional index scores reported byWikander
1998b.
Risk of bias in included studies
Methodological quality was assessed using the quality assessment
tool described by the Cochrane Incontinence Review Group.
Allocation
Three of the trials (Brittain 2000a; Judge 1969; Tibaek 2005) were
classed as A (adequate concealment of allocation). Eight of the
trials (Chu 1997; Lewis 1990; Liu 2006; Gelber 1997a; Gelber
1997b;Wikander 1998b;Zhang 2002;Zhou1999)were classed as
B (unclear). The trial by Zhu (Zhu2003)was a quasi-experimental
study with subjects allocated in sequence according to the time
of admission; allocation was therefore not concealed. The trial by
Brittain (Brittain 2000a) had a 2:1 randomisation.
Blinding
In the trials of complementary therapies (Chu 1997; Liu 2006;
Zhang 2002; Zhou 1999) and meclofenoxate (Zhu 2003), blind-
ing of staff, trial participants and outcome assessment was unclear.
In the trials of professional input interventions (Brittain 2000a;
Wikander 1998b) and pelvic floor muscle training (Tibaek 2005),
health care providers and trial participants could not be blind
to treatment status. Brittain 2000a and Tibaek 2005 used inde-
pendent outcome assessors. In the trial by Wikander (Wikander
1998b), outcomes were assessed by ward staff. In the cross-over
trial of oestrogen versus placebo (Judge 1969), blinding of staff
and trial participants is likely to have been effective, but it was
unclear who undertook outcome assessment.
Follow-up and exclusions
Loss to follow up was unclear in the trial of scalp acupuncture
(Chu 1997). The trial of rehabilitation governed by a functional
independence measure (Wikander 1998b) reported no loss to fol-
low up. It is unclear why there were fewer patients in the con-
trol group (n=13) than the intervention group (n=21). There was
also no reported loss to follow up in the trials of acupuncture
versus usual care (Zhang 2002), eye and scalp acupuncture ver-
sus no acupuncture (Zhou 1999) and meclofenoxate plus salvia
miltirrhiza versus salviamitirrhiza (Zhu 2003). The cross-over trial
of oestrogen versus placebo (Judge 1969) and the trials of pelvic
floor muscle training versus usual care (Tibaek 2005) and ginger-
salt-partitioned moxibustion plus routine acupuncture versus rou-
tine acupuncture (Liu 2006) state numbers and reasons for with-
drawals. In the trial of a Continence Nurse Advisor versus general
practitioner care (Brittain 2000a), the numbers of withdrawals at
three and six months are stated and reasons given, but are not
reported separately for intervention and control group. There was
missing data at both three and six months, because some partici-
pants were not yet due for their assessment when results were re-
ported. The proportions for which data are reported are 82% at
three months, and 63% at six months. Comparisons on age and
gender for those excluded from analyses showed no significant dif-
ferences.
Power calculations and intention-to-treat analyses were not re-
ported in any of the trials, although four trials (Wikander 1998b;
Zhang 2002; Zhou 1999; Zhu 2003) reported complete data and
are therefore likely to have applied intention to treat.
Effects of interventions
1. INTERVENTION VERSUS NO
INTERVENTION/USUAL CARE (Comparison 01)
Nine trials (Brittain 2000a; Chu 1997; Gelber 1997a; Liu 2006;
Tibaek 2005; Wikander 1998b; Zhang 2002; Zhou 1999; Zhu
2003) with a total of 670 participants compared an intervention
to promote urinary continence against no intervention or usual
care. The interventions included:
Behavioural interventions:
• timed voiding versus void on request (Gelber 1997a);
• pelvic floor muscle training versus usual care (Tibaek 2005).
Specialised professional input interventions:
• a special intervention programme based on assessment
using the Functional Independence Measure (FIM) versus usual
rehabilitation care (Wikander 1998b);
• care from a Continence Nurse Advisor (CNP) versus usual
care provided by the general practitioner (GP) (Brittain 2000a).
Complementary therapy interventions:
• scalp acupuncture versus no scalp acupuncture (Chu 1997);
• eye and scalp acupuncture versus no acupuncture (Zhou
1999);
• acupuncture versus usual care (Zhang 2002);
• ginger-salt-partitioned moxibustion plus routine
acupuncture versus routine acupuncture (Liu 2006);
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Pharmacotherapy interventions:
• meclofenoxate plus salvia miltirrhiza versus salvia
miltirrhiza (Zhu 200
Incontinence
Five trials (Brittain 2000a; Liu 2006; Wikander 1998b; Zhang
2002; Zhou 1999) recruiting 485 participants measured number
of people with incontinence after treatment; random effects mod-
els were used for the meta-analysis because of heterogeneity. All
five trials were of specialised professional input interventions or of
complimentary therapy interventions.
Specialist professional input interventions
In both the two trials of structured assessment and management,
the rate of incontinence was lower in the intervention group than
in the control group (Comparison 01.01.01). There was, however,
marked heterogeneity between the trials: Wikander (Wikander
1998b), 1/21 vs. 10/13 (RR 0.06; 95% CI 0.01 to 0.43); Brittain
(Brittain 2000a), 40/73 vs. 31/48 (RR 0.85; 95% CI 0.63 to
1.14). Although the overall RR (0.26) was consistent with a large
treatment effect, applying a random effects model (because of the
heterogeneity) led to a wide confidence interval which was not
statistically significant (0.01 to 4.67; p = 0.36).
Complementary therapy interventions
In the three trials of complementary therapy interventions for
which data were available (Liu 2006; Zhang 2002; Zhou 1999),
the rate of incontinence was reported to be lower in the inter-
vention group and this difference was statistically significant for
two of the studies. This comparison also showed heterogeneity (I
2 = 80.8%). Applying a random effects model, the overall RR was
0.44 (95% CI 0.23 to 0.86; p = 0.02).
Severity of incontinence
Behavioural interventions
One trial (Tibaek 2005) measured the mean number of incon-
tinence episodes in 24 hours. The impact of pelvic floor muscle
training indicated no significant difference (WMD -1.00, 95%CI
-2.74, 0.74, Comparison 01.02.01).
In the trial byGelber (Gelber1997a), timed voidingwas compared
against void on request (which was interpreted as usual care). The
data reported were too few even for tentative conclusions, and no
further data could be obtained from the investigators. The study
was reported as ongoing, but for the purposes of this review was
considered closed.
Urinary symptoms
Behavioural interventions
The impact of pelvic floor muscle training on mean daytime void-
ing frequency (Tibaek 2005) indicated a significant difference
(WMD -2.30, 95% CI -4.14, -0.46, Comparisons 01.04.01).
The impact on mean nighttime voiding frequency indicated no
significant difference (WMD -0.10, 95% CI -0.83, 0.63, Com-
parison 01.07.01).
Specialised professional input interventions
The impact of the Continence Nurse Advisor intervention on the
number of people not cured of urinary symptoms at three months
(Brittain 2000a) indicated a borderline significant difference (48/
89 treatment versus 38/54 control, RR 0.77, 95% CI 0.59, 0.99,
Comparison 01.03.01). No significant difference was found in the
number of people with urinary frequency at three months (98/
120 treatment versus 59/67 control, RR 0.93, 95% CI 0.82, 1.05,
Comparison 01.05.01), the number of people with urinary ur-
gency at three months.(95/121 treatment versus 50/67 control,
RR 1.05, 95% CI 0.89, 1.24, Comparison 01.06.01) or the num-
ber of people with nocturia at three months (102/119 treatment
versus 60/67 control, RR 0.96, 95% CI 0.86, 1.07, Comparison
01.08.01).
There were no data suitable for analysis in RevMan Analyses in
relation to changes in the mean number of symptoms (see ’Char-
acteristics of Included Studies Table’). However, the trial report
suggested that the evidence favoured a Continence Nurse Advisor
compared with usual care in terms of reducing the total number
of symptoms experienced (p<0.01) at three months, with weak
evidence in favour of the Continence Nurse Advisor in reducing
the total number of symptoms at six months (p=0.06) (Brittain
2000a).
There were no data suitable for analysis in RevMan Analyses in re-
lation to changes in day and night-time leakage scores (see ’Char-
acteristics of Included Studies Table’). However, the trial report
suggested that the evidence favoured a Continence Nurse Advisor
compared with usual care in terms of day-time severity of leakage
at three months (p=0.038).
Complementary therapy interventions
The impact of ginger-salt-partitioned moxibustion on mean day-
time voiding frequency (Liu 2006) indicated a significant differ-
ence (WMD -5.57, 95% CI -7.00, -4.14, Comparison 01.04.02).
There was also a significant difference on mean nighttime void-
ing frequency (WMD -3.18, 95% CI -3.95, -2.41, Comparison
01.07.02).
There were no data suitable for analysis in RevMan Analyses in
the trial of scalp acupuncture versus no scalp acupuncture (Chu
1997). After two weeks and two courses of treatment, the investi-
gators reported a reduction in urinary frequency or incontinence
of 90.3% in the intervention group, with two people not regain-
ing “normal urine”, 12 people partly regaining “normal urine”
and 16 people regaining “normal urine”. A significant difference
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between the experimental and control groups was reported as “p
(0.05~0.001)”. No results are reported for the control group. No
further data could be obtained for this study.
Pharmacotherapy interventions
The impact of meclofenoxate indicated a significant difference in
the number of people whose incontinence did not improve (Zhu
2003) (9/40 treatment versus 27/40 control, RR 0.33, 95% CI
0.18, 0.62, Comparison 01.03.02).
Urological measures
Behavioural interventions
One trial (Tibaek 2005) measured mean function of the pelvic
floor muscle. The impact of pelvic floor muscle training indicated
no significant difference (WMD 0.10, 95% CI -0.48, 0.68, Com-
parison 01.09.01).
Health status and quality of life
Behavioural interventions
Tibaek 2005 measured health status in terms of the mean total
score on the SF36. The impact of pelvic floor muscle training in-
dicated no significant difference (WMD -28.00, 95%CI -169.66,
113.66, Comparison 01.10.01). Quality of life was measured us-
ing the mean total score on the IIQ; no significant difference
was found (WMD -3.00, 95% CI -47.87, 41.87, Comparison
01.11.02).
Specialised professional input interventions
Wikander 1998b measured quality of life in terms of mean change
in psychological well-being measured by the Psychological Gen-
eral Well-Being Index. The impact of a functional assessment pro-
gramme indicated a significant difference (WMD -39.00, 95%CI
-51.19, -26.81, Comparison 01.11.01).
Function
Specialised professional input interventions
Wikander 1998b measured function in terms of the number of
people independent in transfer from wheelchair to toilet. The im-
pact of a functional assessment programme indicated a significant
difference (6/21 treatment versus 11/13 control, RR 0.34, 95%
CI 0.17 to 0.69, Comparison 01.13.01).
Pharmacotherapy interventions
One trial measured function in terms of mean Barthel score (Zhu
2003). The impact of meclofenoxate indicated a significant differ-
ence (WMD 3.40, 95% CI 2.85 to 3.95, Comparison 01.12.01).
Patient satisfaction
Specialised professional input interventions
One trial (Brittain 2000a)measured satisfaction in terms of people
not satisfied with the service at three months. The impact of the
Continence Nurse Advisor indicated a significant difference (13/
109 versus 17/45 control, RR 0.32, 95% CI 0.17, 0.59, Compar-
ison 01.14.01).
Cost/service use
Specialised professional input interventions
One trial (Wikander 1998b) measured service use in terms of peo-
ple discharged to a setting other than their home. The impact of
a functional assessment programme indicated a significant differ-
ence (3/21 treatment versus 8/13 control, RR 0.23, 95% CI 0.07
to 0.72, Comparison 01.15.01).
Six month follow-up
Behavioural interventions
Tibaek 2005 measured outcomes at six months and found a pelvic
floor muscle training programme indicated no significant differ-
ence in terms of mean SF36 score (WMD -46.00, 95% CI -
165.05, 73.05) and mean IIQ score (WMD -4.00, 95% CI -
56.17, 48.17).
Specialised professional input interventions
Brittain 2000a measured outcomes at six months and found some
evidence of an impact of the Continence Nurse Advisor in terms
of people with urinary symptoms at 6 months (48/89 treatment
versus 38/54 control, RR 0.77, 95% CI 0.59 to 0.99), but little
difference in terms of the number of people with incontinence
after treatment (75/91 treatment versus 47/55 control, RR 0.96,
95% CI 0.83, 1.11), urinary frequency (73/89 treatment versus
47/54 control, RR 0.94, 95% CI 0.82, 1.09), urinary urgency
(65/91 treatment versus 40/54 control, RR 0.96, 95% CI 0.79,
1.18) and nocturia (77/89 treatment versus 46/53 control, RR
1.00, 95%CI 0.87, 1.14). There were no data suitable for analysis
in RevMan Analyses in relation to changes in the total number of
symptoms; however, the trial report suggested that the evidence
favoured a Continence Nurse Advisor compared with usual care
in terms of reducing the total number of symptoms at six months
(p=0.06).
2. INTERVENTION VERSUS PLACEBO
(Comparison 02)
The only trial assessing this comparisonwas in the pharmacotherapy
interventions category.
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One small cross-over trial (Judge 1969) compared an interven-
tion designed to promote urinary continence (oestrogen) against
placebo in a long term care setting in 13 women with a history of
stroke. Results were reported separately for people with mild or
severe incontinence and in view of the significant heterogeneity
between the two groups; a random effects model was used.
There was evidence in favour of oestrogen in both groups, with a
stronger result in severe incontinence:
• mild incontinence: paired samples mean difference in
number of incontinent episodes per week -1.75; 95% CI -3.31
to -0.19, Comparison 02.01.01 (Judge 1969);
• severe incontinence: paired samples mean difference -6.4;
95% CI -9.47 to -3.33. Comparison 02.01.02 (Judge 1969).
Combined results favoured oestrogen but were not statistically
significant (paired samples mean -3.88 95% CI -8.42 to 0.66)
(Judge 1969).
3. SPECIFIC INTERVENTION VERSUS ANOTHER
INTERVENTION (Comparison 03)
The only trial assessing this comparison compared a behavioural
intervention (timed voiding) with a pharmacotherapy interven-
tion (oxybutinin)(Gelber 1997b). The data were too few for useful
analysis, and no further data could be obtained from the investi-
gators. The study was reported as ongoing, but for the purposes
of this review was considered closed.
4. COMBINED INTERVENTION VERSUS SINGLE
INTERVENTION (Comparison 04)
The only trial assessing this comparision compared a behavioural
intervention with a physical therapy intervention; no studies as-
sessed combinations involving any of the other categories of in-
tervention. Lewis 1990 compared a combined intervention (sen-
sory motor biofeedback plus timed voiding) designed to promote
urinary continence against a single intervention (timed voiding).
The number of incontinence episodes were fewer in the control
group (WMD 2.20; 95%CI 0.12 to 4.28, Comparison 04.02.01)
(Lewis 1990).
D I S C U S S I O N
Summary of main results
The review aimed to consider all interventions designed to treat
urinary incontinence after stroke in adults, rather than testing a
specific hypothesis. Experimental studieswere found testing awide
range of interventions.
Behavioural interventions
The small trial testing pelvic floor muscle training against general
rehabilitation (Tibaek 2005) found evidence in favour of the treat-
ment group in terms of mean voiding frequency over 24 hours and
mean daytime voiding frequency; however findings were only sig-
nificant when outcomes were measured over three rather than two
days. No significant differences were found in the primary out-
come (24 hour pad test) or secondary outcomes including vaginal
palpation of the pelvic floor muscle, the SF36 or the IIQ.
Specialised professional input interventions
One of the two trials testing specialised professional input
(Wikander 1998b) suggests that structured assessment and man-
agement is promising in helping people to regain continence in
the early post-stroke period: this type of intervention merits fur-
ther research. Some features of this trial have to be considered in
interpreting the large effects suggested. Because the intervention
was delivered on a separate ward, equivalence of treatment other
than the intervention could not be assessed, particularly in relation
to staff mix and numbers. The sample size was small, it is not clear
why the numbers in the two trial groups differed, and outcome
measurement was not blinded. Furthermore, if there is an effect,
it is not possible to separate out the influences of structured assess-
ment which could include training of the staff, multi-disciplinary
coordination or the focus provided to staff by regular feedback of
outcome, from the involvement of the patient in the assessment
and management of their care (Wikander 1998b).
The other trial of specialised professional input (Brittain 2000a)
found that outcomes from Continence Nurse Advisor and usual
care groups were similar at all data points, with the exception of
the number of people cured of all urinary symptoms at six months
and satisfaction with the service at three months, where findings
favoured the treatment group (although the confidence intervals
were wide). The intervention used by the Continence Nurse Ad-
visor was well defined, with a structured assessment and interven-
tion protocol. This was particularly appropriate where reasons for
continuing problems with continence had not been investigated.
The generalisability of these results has to take into consideration
the wide definition of urinary incontinence used, which included
people suffering from a range of other urinary symptoms such as
frequency or urgency. While the trial overall was relatively large
and well designed, the proportion of participants for whom results
were available at six months was quite low (63%) and some of the
data could not be analysed.
If there are differences between the two professional input inter-
vention trials, these could be related both to the intensity of the
interventions, and to the type of trial participant. Participants in
the trial byWikander 1998b were between 11-19 days post-stroke
when the hospital-based intervention began, whereas the trial by
Brittain 2000a was conducted in a community setting. This is
likely to have included people with a much less recent stroke. Par-
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ticipants in the trial by Wikander 1998b were also known to have
developed continence problems only subsequent to their stroke,
while this is not known for the other trial (Brittain 2000a).
Complementary therapy interventions
Three trials of complementary therapies found significant differ-
ences favouring the treatment group: acupuncture was more ef-
fective than usual care in terms of people with incontinence after
treatment (Zhang 2002), eye and scalp acupuncture was more ef-
fective than no acupuncture in terms of people with incontinence
after treatment (Zhou 1999) and ginger-salt-partitioned moxi-
bustion plus routine acupuncture was more effective than rou-
tine acupuncture in terms of mean daytime voiding frequency and
mean nighttime voiding frequency (Liu 2006). However, these
trials reported minimal methodological detail and it is likely they
were of poor quality. It is also not clear whether, and how, these
interventions are transferable to the health services of other coun-
tries.
Pharmacotherapy interventions
In the small cross-over trial testing an intervention (oral oestro-
gen) against placebo (Judge 1969), there were fewer incontinence
episodes per week during oestrogen treatment. However, it is only
known that the participants had a history of stroke. The high
mean age of the participants in the trial, the presence of confusion
and lack of mobility, and the setting in which the trial took place
(two geriatric hospitals) suggest that continence problems may
have been secondary to other conditions as well as stroke. For this
reason it is problematic to generalise these results to women after
stroke. Furthermore, the dose prescribed is not that currently rec-
ommended, hormone replacement therapy is anyway now widely
considered to be contraindicated in patients who have had, or are
at risk of, stroke, and there is evidence that oestrogens increase
incontinence in postmenopausal women (Hendrix 2005).
It is notable that the most promising results for regaining conti-
nence were from the Wikander 1998b trial, where the time since
stroke onset of the participants was short. Early intervention could
have greatest impact on the numbers regaining continence. How-
ever, 25% of people discharged from hospital after stroke still have
continence problems. There is a lack of evidence on whether the
many other forms of intervention that have been shown to have
some value in the general population would also be relevant to
people after stroke. In particular, there are no usable results from
trials testing the use of bladder relaxants such as anticholinergics,
or programmes of timed voiding or bladder training.
Overall completeness and applicability of the
evidence
Themajor point of interest in the included studies is themix of cat-
egories of intervention, including physical, behavioural and com-
plementary therapies, drugs, and professional input interventions
such as using trained personnel and specific methods of managing
care. However, within categories it was generally not possible to
combine studies due to use of different outcome measures.
Quality of the evidence
The trials included were generally small (n=724 participants in
total; median =49 participants); only three trials (Brittain 2000a;
Judge 1969; Tibaek 2005) had adequate allocation concealment
and many were limited by poor reporting. For most, it was impos-
sible to judge the extent to which they might have been prone to
bias. The small sample sizes meant that confidence intervals were
wide and did not rule out clinically important differences when
there was no statistically significant difference. Even the largest
trial (Brittain 2000a) is not fully reported, and it has not been
possible to obtain full data from the investigators. The review is
also limited by the lack of full data for four other trials (Chu 1997;
Gelber 1997a; Gelber 1997b; Lewis 1990).
Potential biases in the review process
The original protocol for this review specified inclusion criteria for
participants as having had a stroke in the previous 12 months, but
this definition proved unworkable, because most of the trials did
not specify or report time since stroke. There was also a lack of clar-
ity about whether urinary incontinence was subsequent to stroke.
Only three trials (Liu 2006; Tibaek 2005; Wikander 1998b) spec-
ified that urinary continence problems were subsequent to stroke,
and detailed the time since stroke onset. For this reason, the extent
to which the results for the remaining trials can be generalised to
people with continence problems solely as the result of a stroke is
unclear.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is very little evidence from stroke-specific studies to guide
practice. The lack of trials testing the same category of interven-
tion means that recommendations for practice are based on the
results of a few, usually small, trials. The Wikander 1998b and
Brittain 2000a trials provide some evidence to suggest that spe-
cialised professional input using systematic methods to assess and
manage continence problems may improve some outcomes. The
limited evidence suggests that the greatest impact on urinary in-
continence may be in the acute phase of rehabilitation after stroke.
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However, the Brittain (Brittain 2000a) trial suggests that special-
ist input and individualised care management may improve the
number of symptoms of urinary incontinence even in the longer
term.
Implications for research
Evidence suggesting that beneficial outcomes may be achieved by
structuring the management of care for people with urinary con-
tinence problems following a stroke points to the need for larger
trials. Given the variety of problems that can hinder the mainte-
nance of continence after stroke, the use of individualised assess-
ment and goal setting to tailor interventions to the neurological
and functional problems of the individual would seem to be espe-
cially worthy of consideration.
Methods of managing continuing urinary incontinence such as
intermittent catheterisation or the use of catheter valves are also
needed.
Three trials of complementary therapies, namely acupuncture
(Zhou 1999; Zhang 2002) and ginger-salt-partitioned moxibus-
tion (Liu 2006), suggest these interventions may be worth inves-
tigating further with more rigorous study design.
There is a need for more well-designed studies. Further research
should use standardised definitions and classification systems to
record details of the type and severity of stroke, and the type
and severity of urinary incontinence. Pre-stroke continence status,
time since stroke and stroke recurrence should also be recorded,
with clear inclusion criteria for continence status. Exclusion cri-
teria should be given for comorbidities and clinical indicators of
underlying urogenital or systemic conditions such as infection.
Specific details of structured assessment and intervention proto-
cols need to be given, with standardisation of treatment, measures
of between groups contamination or differences, and tailoring of
intervention to the early or later phases of rehabilitation. Out-
come measures of urinary incontinence and of urinary symptoms
should be standardised, with attention to their validity and relia-
bility and the blinding of outcome assessment. The measurement
of changes in health related quality of life would be valuable. The
time periods for review should be standardised for the acute, early
and later phases of rehabilitation. Lastly, sample size calculations
and secure randomisation at either the cluster or individual patient
level should be used appropriately.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Brittain 2000a
Methods RCT
Setting: at home
Participants 232 male (61%) and female (39%) adult stroke survivors with urinary incontinence.
Inclusion: Stroke diagnosed by self-report (questionnaire) as stroke, subarachnoid haemorrhage or tran-
sient ischaemic attack. Self-reported clinically significant urinary symptoms, including leakage of urine,
stress incontinence, frequency, nocturia or urgency.
Exclusion: Pregnancy, physical causes of urinary tract dysfunction (prolapse, urethral stricture, prostatic
obstruction, pelvic mass ormalignancy in past 5 years), active treatment for incontinence in past 6months,
neurogenic retention, raised post-residual volumes, glycosuria or haematuria
Age 40 to 96 years, mean 70
Interventions A: 152 people allocated toContinence Nurse Practitioner (CNP) assessment and treatment. CNP received
3months training, and used formatted assessment and guidelines for treatment, which could include habit
retraining, pelvic floor awareness, dietary advice, the provision of continence garments, and GP referral
for treatment of atrophic vaginitis, candidiasis or constipation. The intervention comprised six contacts
and five treatment visits at weeks 1, 2, 4, 6 and 8. Week 1: History + physical exam, Week 2: Diagnostic
visit + development of management plan, Weeks 4 and 6: review, adapt + reinforce management plan,
Week 8: re-assessment.
B: 80 people allocated to usual care provided by general practitioner and referral to existing services for
the management of continence
Outcomes Incontinence after treatment at 3 months: A: 40/73, B: 31/48
Incontinence after treatment at 6 months: A: 75/91, B: 47/55
Mean day-time leakage severity at 3 months: A: -0.27, B: +0.05
Mean day-time leakage severity at 6 months: A: -0.69, B: -0.52
Mean night-time leakage severity at 3 months: A: -0.19, B: -0.02
Mean night-time leakage severity at 6 months: A: -0.40, B: +0.02
Urinary frequency at 3 months: A: 98/120, B: 59/67
Urinary frequency at 6 months: A: 73/89, B: 47/54
Urinary urgency at 3 months: A: 95/121, B: 50/67
Urinary urgency at 6 months: A: 65/91, B: 40/54
Nocturia at 3 months: A: 102/119, B: 60/67
Nocturia at 6 months: A: 77/89, B: 46/53
Not cured of all urinary symptoms at 3 months: A: 75.3%, B: 82.1%
Not cured of all urinary symptoms at 6 months: A: 48/89, B: 38/54
Mean number of urinary symptoms at 3 months: A: -0.58, B: -0.41
Mean number of urinary symptoms at 6 months: A: -0.47, B: -0.20
Not satisfied with service: A: 13/109, B: 17/45
Notes Sub sample of the MRC Incontinence Study
2:1 randomisation.
No baseline differences in age and gender between the groups
Proportions for which data reported: 82% at 3 months, 63% at 6 months
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Brittain 2000a (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Chu 1997
Methods RCT
Participants 32 (53%)male and28 (47%) female adult ischaemic stroke survivorswith urinary incontinence/frequency.
Subjects described as having multi-focal cerebral infarction.
Age: male 50-71, female 45-61.
Interventions A: 30 people allocated to scalp acupuncture using the “bai hui” channel. Needle in situ for 1-2 days in hot
weather, and 3-7 days in cold weather. Needle manipulated every 4 hours. Treatment period: 1-2 weeks.
B: 30 people allocated to usual care. No details given.
Outcomes A: people totally regaining “normal urine” = 16/30, partly regaining “normal urine” = 12/30 , not regaining
“normal urine” = 2/30.
B: no results given.
Notes Both groups received acupuncture in the channels “guan yuan” and “san yinjiao” combined with nursing
care, which was interpreted as usual care
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Gelber 1997a
Methods RCT
Participants 37 adult unilateral stroke survivors with urinary incontinence and normal urodynamic studies. Age and
gender mix not given
Interventions A: 8 people allocated to timed voiding
B: 10 people allocated to void on request
No further details given
Outcomes Number of incontinence episodes per day. No numerical results reported
Notes
Risk of bias
17Treatment of urinary incontinence after stroke in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gelber 1997a (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Gelber 1997b
Methods RCT
Participants 37 adult unilateral stroke survivors with urinary incontinence and bladder hyperreflexia. Age and gender
mix not given
Interventions A: 9 people allocated to Oxybutinin
B: 10 people allocated to timed voiding
No further details given
Outcomes Number of incontinence episodes per day. No numerical results reported
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Judge 1969
Methods Cross-over trial
Setting: Long stay geriatric hospitals
Participants 13 females with a diagnosis of cerebrovascular accident or “multiple little strokes” , 7 with mild inconti-
nence (average 12.3 episodes/week), and 6 with severe incontinence (average 41.1 episodes/week).
Inclusion: None stated
Exclusion: Faecal impaction, urinary infection
Age: mean 82, range 66-92
Interventions Oestrogen as Quinestradol 0.25mg 4 times a day for one month or placebo with a wash-out period of
one month
Outcomes Number of incontinent episodes per week:
Group 1 (mildly incontinent) placebo week 10.14 (SD 4.76), active preparation week 8.43 (SD 2.42)
Group 2 (severely incontinent) placebo week 38.80 (SD 5.07), active preparation week 32.4 (SD 2.42)
Notes Participants in group 1 (defined as ’mildly incontinent’) and group 2 (defined as ’severely incontinent’)
were from two different hospitals
Risk of bias
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Judge 1969 (Continued)
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Lewis 1990
Methods RCT
Participants 23 adults with post-stroke urinary urge incontinence.
5 (22%) haemorrhagic stroke, 18 (78%) with ischaemic stroke.
Age and gender mix not given
Interventions A: 11 people allocated to sensory-motor biofeedback device (Uristop) + timed voiding
B: 12 people allocated to timed voiding
Treatment time of 2 weeks.
Outcomes Incontinence after treatment: A: 10/11, B: 10/12
Number of incontinence episodes: A: 5.7 (SD 2.5), B: 3.5 (SD 2.6)
Notes Continence defined as zero incontinence episodes in the last two days of the study
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Liu 2006
Methods RCT
Setting: inpatient
Participants 35 male (47%) and 40 female (53%) adult stroke survivors with urinary incontinence
Inclusion: cerebral infarction or haemorrhage, time between stroke onset and admission to hospital less
than 6 months, continent of urine pre-stroke, presence of urinary incontinence, urgent or frequent
micturition when condition stabilised after stroke, micturition problems affected quality of life, conscious
and able to communicate, normal recognition, aged between 40 and 75 years
Exclusion: co-morbidities involving the heart, kidney or other important organs, pre-stroke chronic urinary
retention and urinary incontinence, unable to communicate, long-standing chronic urinary tract infection
Age: mean 64 years
Interventions A (39): Ginger-salt-partitioned moxibustion at Sheque (CV 8) and routine acupuncture (e.g. Tsusanli,
Yinlingquan).
B (36): Routine acupuncture.
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Liu 2006 (Continued)
Outcomes Mean number of urination times each day: A: 7.03, B: 12.60
Mean number of times requesting toileting at night: A: 1.75, B: 4.93
Number of participants with incontinence at 72 hours: A: 16/39; B: 21/36
Notes No baseline differences in age, gender, type of stroke, stroke course, frequency symptoms and grade of
urinary incontinence between the groups
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Tibaek 2005
Methods RCT
Setting: outpatient
Participants 26 women adult stroke survivors with mixed stress/urge urinary incontinence
Inclusion: women diagnosed with first ever ischaemic stroke according toWHOdefinition and verified by
CAT scan; stroke symptoms in at least 1month; normal cognitive function (mini-mental state examination
score <24); UI according to ICS definition; independent walking ability indoors >100m with/without
aids; independence in toilet visits; age between 40 and 85 years
Exclusion: urinary tract infection; symptom of vaginal prolapse; chronic respiratory diseases; psychiatric
diseases; other neurological diseases; unable to speak Danish
Age: median 60 years
Interventions A (14): Intervention group: “systematic, controlled, intensive pelvic floor muscle (PFM) training pro-
gramme”. Programme consisted of 1) introduction to theory 2) home exercises, including strength PFM
exercise by performing close to maximum contraction (6 sec contraction/6 sec rest) Subjects instructed to
repeat exercise programme gradually 6-10 times in supine, standing and sitting positions, 1-2 times daily.
3) group treatment once per week, including isolating PFM contraction (6 sec contraction/6 sec rest)
and strength exercises (3 sec contraction/3 sec rest, and 6 sec contraction/6 sec rest). All techniques were
repeated 4-8 times while supine, sitting and standing, and also prior to daily activities such as rising,
sitting andwalking. Vaginal palpation was performed to ensure correct contraction, to evaluate contraction
strength and to give feedback to subjects
B (12) Comparison group received normal, general rehabilitation with no specific treatment of urinary
incontinence
Outcomes Two day mean voiding frequency over 24 hours: A: 7.6, B: 9.2
Two day mean daytime voiding frequency: A: 5.9, B: 7.3
Two day mean nighttime voiding frequency: A: 1.7, B: 1.9
Two day mean number of incontinence episodes/24 hours: A: 0.2, B: 1.1
Two day mean number of used pads/24 hours: A: 1.1, B: 2.0
Three day mean voiding frequency over 24 hours: A: 7.6, B: 10.0
Three day mean daytime voiding frequency: A: 5.8, B: 8.1
Three day mean nighttime voiding frequency: A: 1.7, B: 1.8
Three day mean number of incontinence episodes/24 hours: A: 0.2, B: 1.2
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Tibaek 2005 (Continued)
Three day mean number of used pads/24 hours: A: 1.1, B: 1.8
Mean function of pelvic floor muscle: A: 2.3, B: 2.2
Mean strength of pelvic floor muscle: A: 2.6, B: 2.8
Mean static endurance of pelvic floor muscle: A: 23.4, B: 21.3
Mean dynamic endurance of pelvic floor muscle: A:15.7, B: 9.8
Short Form Health Status Questionnaire (SF36) post-intervention: A: 567, B: 595
Short Form Health Status Questionnaire (SF36) at 6 months: A: 550, B: 596
Incontinence Impact Questionnaire (IIQ) post-intervention: A: 44, B:47
Incontinence Impact Questionnaire (IIQ) at 6 months: A: 43, B: 47
Notes No baseline differences in age, number of births or mobility between the groups
Proportions for which data reported: 92% at post-test and 6 months
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Wikander 1998b
Methods RCT
Setting: hospital rehabilitation ward
Participants 15 (43%) male and 19 (57%) female adults admitted to hospital within 1 month of acute hemispheric
stroke
Inclusion: New urinary incontinence since stroke
Exclusion: none specified
Age: mean 74 (SD 6.87)
Interventions A: 21 people allocated to intervention programme based on assessment using the Functional Independence
Measure (FIM). Ward staff educated in use of FIM. Participants assessed on admission and at weekly goal
setting meetings.
B: 13 people allocated to usual rehabilitation care based on Bobath method
Outcomes Incontinence after treatment: A: 1/21, B: 3/13
Functional ability (median values of Katz ADL index scale A-G (B = dependent in 1 activity) A: F/B, B:
F/F
Change in psychological well-being: A: 51.8, B: 12.8
Not discharged to home setting: A: 3/21, B: 8/13
Not independent in transfer from bed to wheelchair: A: 6/21, B: 9/13
Not independent in transfer from wheelchair to toilet: A: 6/21, B: 11/13
Not independent in management of wheelchair: A: 0/21, B: 8/13
Notes Rehabilitation period 75-91 days
No baseline differences in age, gender, side of stroke lesion, time from stroke onset to admission, dura-
tion of hospital stay, dysphasia, functional ability, independence in activities of daily living, mobility or
psychological well-being between groups.
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Wikander 1998b (Continued)
Participants were randomised to two different wards.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Zhang 2002
Methods RCT
Setting: unclear
Participants 38 male (59%) and 26 female (41%) adult stroke survivors with urinary incontinence
Inclusion and exclusion: unclear
Age: range 42-62 years
Interventions A (36): acupuncture at the following points: Tsusanli, Yinlingquan, Sanyinjiao
B (28): general treatment using mannite and other medicines
Outcomes Numbers not regaining continence: A: 6/36, B: 26/28
Notes No description of baseline comparisons
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Zhou 1999
Methods RCT
Setting: unclear
Participants 32 male (40%) and 48 female (60%) adult stroke survivors with urinary incontinence
Inclusion and exclusion: unclear
Interventions A (40): eye acupuncture and electriferous scalp acupuncture once per day, six days per week for 4 weeks
Medication therapy, e.g. Hua Duo Zai shi pill, Xi bi lin, Nao fu kang, vitamins C and E
B (40): Medication therapy, e.g. Hua Duo Zai shi pill, Xi bi lin, Nao fu kang, vitamins C and E
Outcomes Numbers not regaining continence: A: 18/40, B: 32/40
Notes No description of baseline comparisons
Risk of bias
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Zhou 1999 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Zhu 2003
Methods Quasi-experiment
Setting: inpatient
Participants 45 male (56%) and 35 female (44%) adult stroke survivors with urinary incontinence
Inclusion: Acute cerebral infarction confirmed by CT scan, urinary incontinence
Exclusion: Unconscious, mental abnormality
Age: mean 63 years
Interventions A (40): Meclofenoxate 0.3g three times per day for 1 month, in addition to salvia miltirrhiza injection 16
ml, IV, 4 times per day for 2 weeks.
B (40%): salvia miltirrhiza injection 16 ml, IV, 4 times per day for 2 weeks
Outcomes Number whose urinary symptoms did not improve: A: 9/40, B: 27/40
Mean cognitive function: A: 34.5, B: 30.42
Mean activities of daily living: A: 37.4, B: 34.0
Notes Groups described as ’comparable’
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cook 1998 Does not include a measure of continence
Gross 1990 Does not include a measure of continence
Tekeoglu 1998 Does not directly test a method of promoting continence
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D A T A A N D A N A L Y S E S
Comparison 1. INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of people with
incontinence after treatment
5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Professional input
interventions
2 155 Risk Ratio (M-H, Random, 95% CI) 0.26 [0.01, 4.67]
1.2 Complementary therapy
interventions
3 219 Risk Ratio (M-H, Random, 95% CI) 0.44 [0.23, 0.86]
2 Severity of incontinence: mean
number of incontinence
episodes in 24 hours
1 18 Mean Difference (IV, Fixed, 95% CI) -1.0 [-2.74, 0.74]
2.1 Behavioural interventions 1 18 Mean Difference (IV, Fixed, 95% CI) -1.0 [-2.74, 0.74]
3 Urinary symptoms - overall 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Professional input
interventions
1 143 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.59, 0.99]
3.2 Pharmacotherapy
interventions
1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.18, 0.62]
4 Urinary symptoms - frequency
(continuous variables)
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 Behavioural interventions 1 18 Mean Difference (IV, Fixed, 95% CI) -2.3 [-4.14, -0.46]
4.2 Complementary therapy
interventions
1 62 Mean Difference (IV, Fixed, 95% CI) -5.57 [-7.00, -4.14]
5 Urinary symptoms - frequency
(dichotomous variables)
1 187 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.82, 1.05]
5.1 Professional input
interventions
1 187 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.82, 1.05]
6 Urinary symptoms - urgency 1 188 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.89, 1.24]
6.1 Professional input
interventions
1 188 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.89, 1.24]
7 Urinary symptoms - nocturia
(continuous variables)
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 Behavioural interventions 1 18 Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.83, 0.63]
7.2 Complementary therapy
interventions
1 62 Mean Difference (IV, Fixed, 95% CI) -3.18 [-3.95, -2.41]
8 Urinary symptoms - nocturia
(dichotomous variables)
1 186 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.86, 1.07]
8.1 Professional input
interventions
1 186 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.86, 1.07]
9 Urological measures: mean
function of the pelvic floor
muscle
1 23 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.48, 0.68]
9.1 Behavioural interventions 1 23 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.48, 0.68]
10 Health status: mean total score
SF36
1 24 Mean Difference (IV, Fixed, 95% CI) -28.0 [-169.66, 113.
66]
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10.1 Behavioural
interventions
1 24 Mean Difference (IV, Fixed, 95% CI) -28.0 [-169.66, 113.
66]
11 Quality of life 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
11.1 Professional input
interventions
1 34 Mean Difference (IV, Fixed, 95% CI) -39.0 [-51.19, -26.
81]
11.2 Behavioural
interventions
1 24 Mean Difference (IV, Fixed, 95% CI) -3.0 [-47.87, 41.87]
12 Function: mean Barthel score
(continuous variables)
1 80 Mean Difference (IV, Fixed, 95% CI) 3.40 [2.85, 3.95]
12.1 Pharmacotherapy
interventions
1 80 Mean Difference (IV, Fixed, 95% CI) 3.40 [2.85, 3.95]
13 Function: people independent
in transfer from wheelchair to
toilet (dichotomous variables)
1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.17, 0.69]
13.1 Professional input
interventions
1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.17, 0.69]
14 Patient satisfaction 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.17, 0.59]
14.1 Professional input
interventions
1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.17, 0.59]
15 Cost/service use 1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.07, 0.72]
15.1 Professional input
interventions
1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.07, 0.72]
Comparison 3. INTERVENTION VERSUS PLACEBO
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Severity of incontinence: mean
number of incontinence
episodes per week
1 Paired samples mean (Random, 95% CI) -3.88 [-8.42, 0.66]
1.1 Oestrogen versus placebo
(mild incontinence)
1 Paired samples mean (Random, 95% CI) -1.75 [-3.31, -0.19]
1.2 Oestrogen versus placebo
(severe incontinence)
1 Paired samples mean (Random, 95% CI) -6.4 [-9.47, -3.33]
Comparison 5. COMBINED INTERVENTION VERSUS SINGLE INTERVENTION
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of people with
incontinence after treatment
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Sensory-motor
biofeedback device + timed
voiding versus timed voiding
alone
1 23 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.80, 1.49]
25Treatment of urinary incontinence after stroke in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2 Severity of incontinence: mean
number of incontinence
episodes
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Sensory-motor
biofeedback device + timed
voiding vs timed voiding alone
1 23 Mean Difference (IV, Fixed, 95% CI) 2.2 [0.12, 4.28]
Analysis 1.1. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 1
Number of people with incontinence after treatment.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 1 Number of people with incontinence after treatment
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Professional input interventions
Brittain 2000a 40/73 31/48 79.7 % 0.85 [ 0.63, 1.14 ]
Wikander 1998b 1/21 10/13 20.3 % 0.06 [ 0.01, 0.43 ]
Subtotal (95% CI) 94 61 100.0 % 0.26 [ 0.01, 4.67 ]
Total events: 41 (Treatment), 41 (Control)
Heterogeneity: Tau2 = 3.84; Chi2 = 8.70, df = 1 (P = 0.003); I2 =89%
Test for overall effect: Z = 0.91 (P = 0.36)
2 Complementary therapy interventions
Liu 2006 16/39 21/36 34.9 % 0.70 [ 0.44, 1.12 ]
Zhang 2002 6/36 26/28 28.2 % 0.18 [ 0.09, 0.38 ]
Zhou 1999 18/40 32/40 36.9 % 0.56 [ 0.39, 0.82 ]
Subtotal (95% CI) 115 104 100.0 % 0.44 [ 0.23, 0.86 ]
Total events: 40 (Treatment), 79 (Control)
Heterogeneity: Tau2 = 0.27; Chi2 = 10.41, df = 2 (P = 0.01); I2 =81%
Test for overall effect: Z = 2.40 (P = 0.017)
0.01 0.1 1 10 100
Favours treatment Favours control
26Treatment of urinary incontinence after stroke in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 2
Severity of incontinence: mean number of incontinence episodes in 24 hours.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 2 Severity of incontinence: mean number of incontinence episodes in 24 hours
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Behavioural interventions
Tibaek 2005 10 0.2 (0.3) 8 1.2 (2.5) 100.0 % -1.00 [ -2.74, 0.74 ]
Total (95% CI) 10 8 100.0 % -1.00 [ -2.74, 0.74 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 3
Urinary symptoms - overall.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 3 Urinary symptoms - overall
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Brittain 2000a 48/89 38/54 100.0 % 0.77 [ 0.59, 0.99 ]
Subtotal (95% CI) 89 54 100.0 % 0.77 [ 0.59, 0.99 ]
Total events: 48 (Treatment), 38 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.044)
2 Pharmacotherapy interventions
Zhu 2003 9/40 27/40 100.0 % 0.33 [ 0.18, 0.62 ]
Subtotal (95% CI) 40 40 100.0 % 0.33 [ 0.18, 0.62 ]
Total events: 9 (Treatment), 27 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.51 (P = 0.00045)
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Analysis 1.4. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 4
Urinary symptoms - frequency (continuous variables).
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 4 Urinary symptoms - frequency (continuous variables)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Behavioural interventions
Tibaek 2005 10 5.8 (1) 8 8.1 (2.5) 100.0 % -2.30 [ -4.14, -0.46 ]
Subtotal (95% CI) 10 8 100.0 % -2.30 [ -4.14, -0.46 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.45 (P = 0.014)
2 Complementary therapy interventions
Liu 2006 32 7.03 (2.09) 30 12.6 (3.46) 100.0 % -5.57 [ -7.00, -4.14 ]
Subtotal (95% CI) 32 30 100.0 % -5.57 [ -7.00, -4.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.61 (P < 0.00001)
Test for subgroup differences: Chi2 = 7.55, df = 1 (P = 0.01), I2 =87%
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Analysis 1.5. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 5
Urinary symptoms - frequency (dichotomous variables).
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 5 Urinary symptoms - frequency (dichotomous variables)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Brittain 2000a 98/120 59/67 100.0 % 0.93 [ 0.82, 1.05 ]
Total (95% CI) 120 67 100.0 % 0.93 [ 0.82, 1.05 ]
Total events: 98 (Treatment), 59 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.21 (P = 0.23)
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Analysis 1.6. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 6
Urinary symptoms - urgency.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 6 Urinary symptoms - urgency
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Brittain 2000a 95/121 50/67 100.0 % 1.05 [ 0.89, 1.24 ]
Total (95% CI) 121 67 100.0 % 1.05 [ 0.89, 1.24 ]
Total events: 95 (Treatment), 50 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
30Treatment of urinary incontinence after stroke in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.7. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 7
Urinary symptoms - nocturia (continuous variables).
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 7 Urinary symptoms - nocturia (continuous variables)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Behavioural interventions
Tibaek 2005 10 1.7 (0.6) 8 1.8 (0.9) 100.0 % -0.10 [ -0.83, 0.63 ]
Subtotal (95% CI) 10 8 100.0 % -0.10 [ -0.83, 0.63 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
2 Complementary therapy interventions
Liu 2006 32 1.75 (1.07) 30 4.93 (1.89) 100.0 % -3.18 [ -3.95, -2.41 ]
Subtotal (95% CI) 32 30 100.0 % -3.18 [ -3.95, -2.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.08 (P < 0.00001)
Test for subgroup differences: Chi2 = 32.48, df = 1 (P = 0.00), I2 =97%
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Analysis 1.8. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 8
Urinary symptoms - nocturia (dichotomous variables).
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 8 Urinary symptoms - nocturia (dichotomous variables)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Brittain 2000a 102/119 60/67 100.0 % 0.96 [ 0.86, 1.07 ]
Total (95% CI) 119 67 100.0 % 0.96 [ 0.86, 1.07 ]
Total events: 102 (Treatment), 60 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.43)
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Analysis 1.9. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 9
Urological measures: mean function of the pelvic floor muscle.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 9 Urological measures: mean function of the pelvic floor muscle
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Behavioural interventions
Tibaek 2005 11 2.3 (0.9) 12 2.2 (0.4) 100.0 % 0.10 [ -0.48, 0.68 ]
Total (95% CI) 11 12 100.0 % 0.10 [ -0.48, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 10
Health status: mean total score SF36.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 10 Health status: mean total score SF36
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Behavioural interventions
Tibaek 2005 12 567 (173) 12 595 (181) 100.0 % -28.00 [ -169.66, 113.66 ]
Total (95% CI) 12 12 100.0 % -28.00 [ -169.66, 113.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 11
Quality of life.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 11 Quality of life
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Professional input interventions
Wikander 1998b 21 -51.8 (20.6) 13 -12.8 (15.5) 100.0 % -39.00 [ -51.19, -26.81 ]
Subtotal (95% CI) 21 13 100.0 % -39.00 [ -51.19, -26.81 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.27 (P < 0.00001)
2 Behavioural interventions
Tibaek 2005 12 44 (53) 12 47 (59) 100.0 % -3.00 [ -47.87, 41.87 ]
Subtotal (95% CI) 12 12 100.0 % -3.00 [ -47.87, 41.87 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.90)
Test for subgroup differences: Chi2 = 2.30, df = 1 (P = 0.13), I2 =57%
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Analysis 1.12. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 12
Function: mean Barthel score (continuous variables).
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 12 Function: mean Barthel score (continuous variables)
Study or subgroup Control Treatment
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pharmacotherapy interventions
Zhu 2003 40 37.4 (1.2) 40 34 (1.3) 100.0 % 3.40 [ 2.85, 3.95 ]
Total (95% CI) 40 40 100.0 % 3.40 [ 2.85, 3.95 ]
Heterogeneity: not applicable
Test for overall effect: Z = 12.15 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 13
Function: people independent in transfer from wheelchair to toilet (dichotomous variables).
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 13 Function: people independent in transfer from wheelchair to toilet (dichotomous variables)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Wikander 1998b 6/21 11/13 100.0 % 0.34 [ 0.17, 0.69 ]
Total (95% CI) 21 13 100.0 % 0.34 [ 0.17, 0.69 ]
Total events: 6 (Treatment), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.98 (P = 0.0029)
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Analysis 1.14. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 14
Patient satisfaction.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 14 Patient satisfaction
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Brittain 2000a 13/109 17/45 100.0 % 0.32 [ 0.17, 0.59 ]
Total (95% CI) 109 45 100.0 % 0.32 [ 0.17, 0.59 ]
Total events: 13 (Treatment), 17 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.57 (P = 0.00036)
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Analysis 1.15. Comparison 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE, Outcome 15
Cost/service use.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 1 INTERVENTION VERSUS NO INTERVENTION/USUAL CARE
Outcome: 15 Cost/service use
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Professional input interventions
Wikander 1998b 3/21 8/13 100.0 % 0.23 [ 0.07, 0.72 ]
Total (95% CI) 21 13 100.0 % 0.23 [ 0.07, 0.72 ]
Total events: 3 (Treatment), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.53 (P = 0.011)
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Analysis 3.1. Comparison 3 INTERVENTION VERSUS PLACEBO, Outcome 1 Severity of incontinence:
mean number of incontinence episodes per week.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 3 INTERVENTION VERSUS PLACEBO
Outcome: 1 Severity of incontinence: mean number of incontinence episodes per week
Study or subgroup
Paired
samples
mean (SE)
Paired
samples mean Weight
Paired
samples mean
IV,Random,95% CI IV,Random,95% CI
1 Oestrogen versus placebo (mild incontinence)
Judge 1969 -1.75 (0.796) 54.2 % -1.75 [ -3.31, -0.19 ]
Subtotal (95% CI) 54.2 % -1.75 [ -3.31, -0.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.20 (P = 0.028)
2 Oestrogen versus placebo (severe incontinence)
Judge 1969 -6.4 (1.568) 45.8 % -6.40 [ -9.47, -3.33 ]
Subtotal (95% CI) 45.8 % -6.40 [ -9.47, -3.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.08 (P = 0.000045)
Total (95% CI) 100.0 % -3.88 [ -8.42, 0.66 ]
Heterogeneity: Tau2 = 9.27; Chi2 = 6.99, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 1.67 (P = 0.094)
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Analysis 5.1. Comparison 5 COMBINED INTERVENTION VERSUS SINGLE INTERVENTION, Outcome 1
Number of people with incontinence after treatment.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 5 COMBINED INTERVENTION VERSUS SINGLE INTERVENTION
Outcome: 1 Number of people with incontinence after treatment
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sensory-motor biofeedback device + timed voiding versus timed voiding alone
Lewis 1990 10/11 10/12 100.0 % 1.09 [ 0.80, 1.49 ]
Subtotal (95% CI) 11 12 100.0 % 1.09 [ 0.80, 1.49 ]
Total events: 10 (Treatment), 10 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 5.2. Comparison 5 COMBINED INTERVENTION VERSUS SINGLE INTERVENTION, Outcome 2
Severity of incontinence: mean number of incontinence episodes.
Review: Treatment of urinary incontinence after stroke in adults
Comparison: 5 COMBINED INTERVENTION VERSUS SINGLE INTERVENTION
Outcome: 2 Severity of incontinence: mean number of incontinence episodes
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sensory-motor biofeedback device + timed voiding vs timed voiding alone
Lewis 1990 11 5.7 (2.5) 12 3.5 (2.6) 100.0 % 2.20 [ 0.12, 4.28 ]
Subtotal (95% CI) 11 12 100.0 % 2.20 [ 0.12, 4.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.039)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. Search methods and terms used for the extra specific searching for this review
Due to the comprehensive nature of the searches already performed by the Stroke Collaborative Review Group, no additional searches
were performed other than on CINAHL, combining stroke terms with terms for urinary incontinence without a research methods
filter. This was done because of the potentially poor indexing of nursing research. The following strategy was used to search CINAHL
(January 1982 to January 2007) on Dialog Datastar:
1. Urination-disorders#.de
2. Urinary-tract-infections#.de
3. Bladder-neurogenic.de
4. Bowel-and-bladder-management#.de
5. Urologic-nursing.de
6. Urologic-care.de
7. Catheters-urinary#.de
8. Catheter-care-urinary#.de
9. Urinary-catheterization#.de
10. Urinary-bladder-irrigation.de
11. Catheter-irrigation-urinary.de
12. Diagnosis-urologic#.de
13. Urinary-tract-physiology#.de
14. Incontinence-aids#.de
15. Urinary-incontinence-and frequency-comfort-questionnaire.de
16. Tube-care-urinary-IOWA-NIC.de
17. Urinary-catheterisation-IOWA-NIC.de
18. Urinary-elimination-management-IOWA-NIC.de
19. Urinary-incontinence-care-IOWA-NIC.de
20. Urinary-retention-care-IOWA-NIC.de
21. Urinary-continence-IOWA-NOC.de
22. Urinary-elimination-IOWA-NOC.de
23. Altered-urinary-elimination-NANDA#.de
24. Urinary-elimination-component-SABA-HHCC#.de
25. Genito-urinary-function-OMAHA.de
26. Urin$ or bladder or urethra$).ti,ab.
27. Catheterization.w..de
28. Catheters.w..de
29. Catheter-care.de
30. Catheter-occlusion.de
31. Catheter-removal.de
32. Tube-removal.de
33. Catheter-placement-determination.de
34. Catheter-related-complications#.de
35. 26 and (27 or 28 or 29 or 30 or 31 or 32 or 33 or 34)
36. Void$ near (difficult$ or impair$ or problem$ or disorder$ or impair$ or control$)
37. 36.ti or 36.ab
38. Urin$ with (incontinen$ or continen$)
39. 38.ti or 38.ab
40. Bladder with (incontin$ or continen$)
41. 40.ti or 40.ab
42. Detrusor with (instability or stability or stable or unstable)
43. 42.ti or 42.ab
44. Bladder with (instability or stability or stable or unstable)
45. 44.ti or 44.ab
38Treatment of urinary incontinence after stroke in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
46. (stress or urge or pad$) with (continen$ or incontinen$)
47. 46.ti or 46.ab
48. Urodynamic$.ti or urodynamic$.ab
49. 37 or 39 or 41 or 43 or 45 or 47 or 48
50. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
or 25
51. 35 or 49 or 50
Key: # = explode, .de = index word, $ = wild card.
The above search was combined with the CINAHL search from the Cochrane Stroke Group.
Recent unpublished trial data were also searched for on national and international databases i.e. NHS National Research Register,
NHS Research Findings Register, US Community of Science NIH Grants, MetaRegister of Controlled Clinical Trials and CRISP, by
adapting terms drawn from the existing search strategies of the Incontinence and Stroke Review Groups.
The reference lists of all relevant reviews and trial reports were searched to identify further relevant studies. Major investigators were
contacted to ask for any other possible relevant trials, published or unpublished. In addition, contact was made with the authors of
other relevant Cochrane reviews to ascertain whether defined subgroups of stroke survivors were identified in trials testing methods of
promoting continence in a general population.
The review was publicised on the following websites: Joanna Briggs Institute, Royal College of Nursing Research Society, Royal College
of Nursing Continence Interest Group, Association of Continence Advisors, Sigma Theta Tau.
We did not impose any language or other restrictions on any of these searches.
WH A T ’ S N E W
Last assessed as up-to-date: 13 November 2007.
Date Event Description
13 October 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 3, 2005
Date Event Description
14 November 2007 New citation required and conclusions have changed Substantive amendment. Five new studies added
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